Markets:

Overview

News

Currencies

International

Treasuries

Intellia Therapeutics, Inc. - Common Stock (NQ:NTLA)

13.46 -0.44 (-3.13%)

Streaming Delayed Price Updated: 3:59 PM EDT, Mar 10, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Intellia Therapeutics, Inc. - Common Stock

< Previous 1 2

...

9 10 11 12 13 14 15 16 17

...

20 21 Next >

Why Is Intellia (NTLA) Stock Up 5% Today? ↗

June 12, 2023

NTLA stock is trending on social media and is up over 5%. The drugmaker reported new, positive results from its gene-edited treatment.

Via InvestorPlace

Intellia Therapeutics Surges As CRISPR Gene-Editing Drug Potentially Cures Swelling Disease ↗

June 12, 2023

The company is testing a treatment for hereditary angioedemia, a potentially fatal swelling disorder.

Via Investor's Business Daily

Why Intellia Therapeutics Stock Is Rising Monday ↗

June 12, 2023

Intellia Therapeutics Inc (NASDAQ: NTLA) shares are trading higher Monday after the clinical-stage genome editing company announced data for its treatment for people living with hereditary angioedema...

Via Benzinga

Chinook Therapeutics, Oracle And Other Big Stocks Moving Higher In Monday's Pre-Market Session ↗

June 12, 2023

U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session. Chinook Therapeutics, Inc. (NASDAQ: KDNY) shares jumped 66.8% to $40.01 in...

Via Benzinga

Can This Gene-Editing Stock Deliver 10X Returns? ↗

June 08, 2023

Buying shares of Intellia Therapeutics might be a smart move.

Via The Motley Fool

12 Analysts Have This to Say About Intellia Therapeutics ↗

May 05, 2023

Via Benzinga

Intellia Therapeutics: Q1 Earnings Insights ↗

May 04, 2023

Via Benzinga

Intellia Therapeutics's Earnings Outlook ↗

May 03, 2023

Via Benzinga

Where Intellia Therapeutics Stands With Analysts ↗

March 31, 2023

Via Benzinga

Analyst Ratings for Intellia Therapeutics ↗

March 14, 2023

Via Benzinga

Wall Street Says These 2 Stocks May Double. Should You Buy Them? ↗

June 05, 2023

Both of these stocks have declined over the past year.

Via The Motley Fool

Cathie Wood Is Loading Up on These 3 Stocks Down 70% or More. Should You? ↗

May 16, 2023

The Ark Invest CEO is betting on rebounds for these beaten-down stocks.

Via The Motley Fool

Why Intellia Therapeutics Shares Are Surging Today ↗

May 04, 2023

Intellia Therapeutics, Inc. (NASDAQ: NTLA) shares are up Thursday as its Q1 results surpassed estimates. The company looks forward to sharing new interim data from NTLA-2001 and NTLA-2002...

Via Benzinga

The 3 Most Promising Gene Editing Stocks to Buy in 2023 ↗

April 28, 2023

Intellia, Beam, and Editas are using gene editing to cure incurable diseases. These are three gene editing stocks you'll want to invest in.

Via InvestorPlace

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗

April 28, 2023

Via The Motley Fool

3 Biotech Stocks to Watch After Johnson & Johnson’s Earnings Beat ↗

April 25, 2023

Discover the latest picks in the biotech industry with our article on 3 biotech stocks to watch after Johnson & Johnson’s earnings beat.

Via InvestorPlace

3 High-Growth Biotech Stocks Poised for Success in 2023 ↗

April 18, 2023

If you look for growth opportunities wherever you can find them, there are some high-growth biotech stocks that could present an opportunity

Via InvestorPlace

2 Monster Growth Stocks That Can Double in Value, According to Wall Street ↗

April 14, 2023

These stocks have some promising growth opportunities, but they also come with a fair amount of risk.

Via The Motley Fool

Why Are Gene-Editing Stocks CRSP, EDIT, NTLA Stock Up Today? ↗

April 13, 2023

While CRSPR stock captured the spotlight for potentially encouraging drug data, the news lifted other gene-editing stocks.

Via InvestorPlace

Benzinga's Top Ratings Upgrades, Downgrades For April 13, 2023 ↗

April 13, 2023

Via Benzinga

Consolidated Communications, CRISPR Therapeutics And Other Big Stocks Moving Higher On Thursday ↗

April 13, 2023

U.S. stocks traded higher, with the Dow Jones gaining over 100 points on Thursday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Cathie Wood Loads Up On Biotech Stocks — Continues To Raise Stake In Coinbase Global ↗

April 06, 2023

Via Benzinga

7 Biotech Stocks to Buy for Breakthrough Treatments and Cures ↗

March 29, 2023

For those that can handle the heat, these biotech stocks to buy undergird some of the most powerful innovations in medicine.

Via InvestorPlace

The 3 Best CRISPR Stocks to Buy Now Before They Skyrocket ↗

March 25, 2023

Moving forward, CRISPR could revolutionize the way we treat thousands of diseases. The best CRISPR stocks will profit from it.

Via InvestorPlace

Benzinga's Top Ratings Upgrades, Downgrades For March 21, 2023 ↗

March 21, 2023

Via Benzinga

3 Beaten-Down Stocks That Could Soar This Year ↗

March 18, 2023

These stocks could enjoy big rebounds in 2023.

Via The Motley Fool

Got $2,000? 3 Growth Stocks to Buy That Could Double Your Money ↗

March 17, 2023

There are no guarantees that any stock will generate huge returns. But the odds look pretty good for these three growth stocks.

Via The Motley Fool

Benzinga's Top Ratings Upgrades, Downgrades For March 14, 2023 ↗

March 14, 2023

Via Benzinga

2 Cathie Wood Stocks That Have Tripled Since the 2020 Market Crash ↗

March 09, 2023

Are these stocks still good buys today?

Via The Motley Fool

7 Cathie Wood Stocks for Your March Buy List ↗

March 07, 2023

These top Cathie Wood stocks are just now attempting to pivot higher after a miserable outing for much of 2022.

Via InvestorPlace

< Previous 1 2

...

9 10 11 12 13 14 15 16 17

...

20 21 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.